These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 21799528)
1. Funding in the firing line. Do governments have a duty to fund the full spectrum of scientific research, or can the private sector be relied upon to pick up the slack? Wolinsky H EMBO Rep; 2011 Jul; 12(8):772-4. PubMed ID: 21799528 [No Abstract] [Full Text] [Related]
2. Public funding and private investment for R&D: a survey in China's pharmaceutical industry. Qiu L; Chen ZY; Lu DY; Hu H; Wang YT Health Res Policy Syst; 2014 Jun; 12():27. PubMed ID: 24925505 [TBL] [Abstract][Full Text] [Related]
8. The perils of subsidiarity. Nat Biotechnol; 2004 Dec; 22(12):1483. PubMed ID: 15583638 [No Abstract] [Full Text] [Related]
9. Private Funding for Pancreatic Cancer Research: More Than a Chip Shot. Hendifar AE; Davies L; Tuli R Gastroenterology; 2017 Apr; 152(5):918-921.e2. PubMed ID: 28259790 [No Abstract] [Full Text] [Related]
10. The potential of health sector non-governmental organizations: policy options. Gilson L; Sen PD; Mohammed S; Mujinja P Health Policy Plan; 1994 Mar; 9(1):14-24. PubMed ID: 10133097 [TBL] [Abstract][Full Text] [Related]
11. Hong Kong domestic health spending: financial years 1989/90 to 2012/13. Tin KY; Song W; Tsoi PK; Lee YH; Chong DS; Lam DW; Yeung AY; Ma ES; Maw CK Hong Kong Med J; 2016 Jun; 22(3 Suppl 3):1-24. PubMed ID: 27389870 [No Abstract] [Full Text] [Related]
12. Brazilian healthcare in the context of austerity: private sector dominant, government sector failing. Costa NDR Cien Saude Colet; 2017 Apr; 22(4):1065-1074. PubMed ID: 28444034 [TBL] [Abstract][Full Text] [Related]
13. [The financial risks in the functioning of the non-governmental medical organizations]. Kucherenko VZ; Shliapnikov VV Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med; 2008; (1):21-3. PubMed ID: 18649689 [No Abstract] [Full Text] [Related]
14. The borders of solidarity: how countries determine the public/private mix in spending and the impact on health care. Flood CM; Stabile M; Tuohy CH Health Matrix Clevel; 2002; 12(2):297-356. PubMed ID: 12430358 [No Abstract] [Full Text] [Related]
15. Changing the public-private mix: an assessment of the health reforms in Greece. Liaropoulos LL; Kaitelidou D Health Care Anal; 1998 Dec; 6(4):277-85. PubMed ID: 10345933 [TBL] [Abstract][Full Text] [Related]
16. Public spending for health care approaches 60 percent. Fox DM; Fronstin P Health Aff (Millwood); 2000; 19(2):271-4. PubMed ID: 10718043 [No Abstract] [Full Text] [Related]
17. Defending the public health system. Armstrong F Aust Nurs J; 2001 Jun; 8(11):18-20. PubMed ID: 11894556 [No Abstract] [Full Text] [Related]
18. The private sector role in HIV/AIDS in the context of an expanded global response: expenditure trends in five sub-Saharan African countries. Sulzbach S; De S; Wang W Health Policy Plan; 2011 Jul; 26 Suppl 1():i72-84. PubMed ID: 21729920 [TBL] [Abstract][Full Text] [Related]
19. Business, households, and governments: health care costs, 1990. Levit KR; Cowan CA Health Care Financ Rev; 1991; 13(2):83-93. PubMed ID: 10122364 [TBL] [Abstract][Full Text] [Related]
20. Sovereign systems. Mathieson S Health Serv J; 2002 Sep; 112(5824):suppl 3-6. PubMed ID: 12369242 [No Abstract] [Full Text] [Related] [Next] [New Search]